ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	11/41	134/7206	1.19540322085e-10
ko05166	HTLV-I infection	12/41	292/7206	4.30708941687e-08
ko04933	AGE-RAGE signaling pathway in diabetic complications	8/41	135/7206	6.99809273217e-07
ko04659	Th17 cell differentiation	7/41	106/7206	1.81968186392e-06
ko05161	Hepatitis B	8/41	173/7206	4.56093154461e-06
ko04657	IL-17 signaling pathway	6/41	87/7206	8.33955610353e-06
ko04010	MAPK signaling pathway	10/41	321/7206	8.73549987885e-06
ko04658	Th1 and Th2 cell differentiation	6/41	96/7206	1.47437500221e-05
ko04668	TNF signaling pathway	6/41	120/7206	5.25382099278e-05
ko04218	Cellular senescence	7/41	177/7206	5.31804130651e-05
ko04660	T cell receptor signaling pathway	6/41	124/7206	6.31605984844e-05
ko05142	Chagas disease (American trypanosomiasis)	6/41	130/7206	8.22538315241e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	7/41	191/7206	8.62248140076e-05
ko05210	Colorectal cancer	5/41	86/7206	0.000115106327301
ko04662	B cell receptor signaling pathway	5/41	88/7206	0.000128405900562
ko04620	Toll-like receptor signaling pathway	5/41	100/7206	0.000234718631946
ko05321	Inflammatory bowel disease (IBD)	4/41	56/7206	0.000267559795146
ko05200	Pathways in cancer	10/41	492/7206	0.000327632499115
ko04210	Apoptosis	6/41	180/7206	0.000485703593493
ko05140	Leishmaniasis	4/41	75/7206	0.000819024386704
ko04917	Prolactin signaling pathway	4/41	87/7206	0.00142793458036
ko05323	Rheumatoid arthritis	4/41	89/7206	0.00155355027546
ko05164	Influenza A	5/41	167/7206	0.00240255298792
ko05168	Herpes simplex infection	5/41	182/7206	0.00348735517718
ko04024	cAMP signaling pathway	6/41	279/7206	0.004581521312
ko04630	Jak-STAT signaling pathway	4/41	132/7206	0.00644861171139
ko04610	Complement and coagulation cascades	3/41	79/7206	0.010023355534
ko05212	Pancreatic cancer	3/41	83/7206	0.0114651645793
ko04621	NOD-like receptor signaling pathway	4/41	157/7206	0.011741071033
ko05220	Chronic myeloid leukemia	3/41	85/7206	0.0122287715008
ko04920	Adipocytokine signaling pathway	3/41	89/7206	0.0138423126786
ko05031	Amphetamine addiction	3/41	91/7206	0.0146925657862
ko05120	Epithelial cell signaling in Helicobacter pylori infection	3/41	92/7206	0.0151286247607
ko05418	Fluid shear stress and atherosclerosis	4/41	173/7206	0.0162772518294
ko05211	Renal cell carcinoma	3/41	96/7206	0.0169460927224
ko05132	Salmonella infection	3/41	98/7206	0.0178989457618
ko04672	Intestinal immune network for IgA production	2/41	37/7206	0.0185508164228
ko04310	Wnt signaling pathway	4/41	181/7206	0.0189089608125
ko04623	Cytosolic DNA-sensing pathway	2/41	41/7206	0.0225166575059
ko05169	Epstein-Barr virus infection	4/41	206/7206	0.0287837810781
ko04921	Oxytocin signaling pathway	4/41	209/7206	0.0301418937626
ko05162	Measles	3/41	120/7206	0.0303376799237
ko04624	Toll and Imd signaling pathway	2/41	49/7206	0.0313854121785
ko04066	HIF-1 signaling pathway	3/41	123/7206	0.0323120259218
ko01522	Endocrine resistance	3/41	124/7206	0.0329848941228
ko05145	Toxoplasmosis	3/41	126/7206	0.0343527034132
ko04930	Type II diabetes mellitus	2/41	54/7206	0.0375187378936
ko05231	Choline metabolism in cancer	3/41	134/7206	0.0401165597982
ko04931	Insulin resistance	3/41	137/7206	0.0423977475028
ko04144	Endocytosis	5/41	342/7206	0.0431680871086
ko04622	RIG-I-like receptor signaling pathway	2/41	62/7206	0.0481938696093